Telix Pharmaceuticals, established in 2018 and headquartered in North Melbourne, Australia, is a radiopharmaceutical company, develops molecularly targeted radiation products for unmet needs in cancer care in Australia, Belgium, Japan, and the Uni...
Lead global regulatory strategy and submissions for Telix’s radiopharmaceutical portfolio, driving IND/BLA/MAA filings and agency interactions to support product approvals and international roll-out.